Scientists dig into past data to see why some tumors respond to antibody drugs
NCT ID NCT07584044
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study reviews medical records from 300 adults with various cancers who received antibody-based therapies. Researchers want to understand how the tumor's surroundings (microenvironment) influence treatment success. The goal is to find patterns that could help predict which patients benefit most from these drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR MICROENVIRONMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.